Published in J Immunol on November 01, 1989
Life below the gum line: pathogenic mechanisms of Porphyromonas gingivalis. Microbiol Mol Biol Rev (1998) 6.28
Structural study on the free lipid A isolated from lipopolysaccharide of Porphyromonas gingivalis. J Bacteriol (1995) 1.61
Evidence that the serotype b antigenic determinant of Actinobacillus actinomycetemcomitans Y4 resides in the polysaccharide moiety of lipopolysaccharide. Infect Immun (1991) 1.44
Porphyromonas gingivalis virulence in mice: induction of immunity to bacterial components. Infect Immun (1992) 1.44
Prevention of Porphyromonas gingivalis-induced oral bone loss following immunization with gingipain R1. Infect Immun (2001) 1.19
Influence of immunization on Porphyromonas gingivalis colonization and invasion in the mouse chamber model. Infect Immun (1992) 1.18
Phagocytosis of virulent Porphyromonas gingivalis by human polymorphonuclear leukocytes requires specific immunoglobulin G. Infect Immun (1991) 1.18
Contribution of Porphyromonas gingivalis lipopolysaccharide to periodontitis. Periodontol 2000 (2010) 1.17
Porphyromonas gingivalis galE is involved in lipopolysaccharide O-antigen synthesis and biofilm formation. Infect Immun (2006) 1.17
Resistance of a Tn4351-generated polysaccharide mutant of Porphyromonas gingivalis to polymorphonuclear leukocyte killing. Infect Immun (1995) 1.07
The native 67-kilodalton minor fimbria of Porphyromonas gingivalis is a novel glycoprotein with DC-SIGN-targeting motifs. J Bacteriol (2010) 0.99
The K1 serotype capsular polysaccharide of Porphyromonas gingivalis elicits chemokine production from murine macrophages that facilitates cell migration. Infect Immun (2006) 0.95
A novel approach for detecting an immunodominant antigen of Porphyromonas gingivalis in diagnosis of adult periodontitis. Clin Diagn Lab Immunol (1998) 0.92
Host response mechanisms in periodontal diseases. J Appl Oral Sci (2015) 0.90
Immunization with Porphyromonas gingivalis capsular polysaccharide prevents P. gingivalis-elicited oral bone loss in a murine model. Infect Immun (2003) 0.90
Prostaglandin E release from human monocytes treated with lipopolysaccharides isolated from Bacteroides intermedius and Salmonella typhimurium: potentiation by gamma interferon. Infect Immun (1991) 0.81
Scavenger receptor A is expressed by macrophages in response to Porphyromonas gingivalis, and participates in TNF-alpha expression. Oral Microbiol Immunol (2009) 0.81
Induction of lethal shock and tolerance by Porphyromonas gingivalis lipopolysaccharide in D-galactosamine-sensitized C3H/HeJ mice. Infect Immun (1999) 0.79
Relationship between hydroxy fatty acids and prostaglandin E2 in gingival tissue. Infect Immun (1998) 0.78
Actinobacillus actinomycetemcomitans in human periodontal disease. J Clin Periodontol (1985) 5.85
Prevalence of periodontitis in adults in the United States: 2009 and 2010. J Dent Res (2012) 5.57
Black-pigmented Bacteroides species, Capnocytophaga species, and Actinobacillus actinomycetemcomitans in human periodontal disease: virulence factors in colonization, survival, and tissue destruction. J Dent Res (1984) 5.29
Actinobacillus actinomycetemcomitans in human periodontal disease: a cross-sectional microbiological investigation. Infect Immun (1980) 4.87
Periodontal disease and risk of cerebrovascular disease: the first national health and nutrition examination survey and its follow-up study. Arch Intern Med (2000) 3.82
Identification of periodontal pathogens in atheromatous plaques. J Periodontol (2000) 3.45
Assessment of risk for periodontal disease. I. Risk indicators for attachment loss. J Periodontol (1994) 3.20
Periodontal disease and diabetes mellitus: a two-way relationship. Ann Periodontol (1998) 3.12
Specificity of salivary-bacterial interactions: role of terminal sialic acid residues in the interaction of salivary glycoproteins with Streptococcus sanguis and Streptococcus mutans. Infect Immun (1978) 3.12
Serology of oral Actinobacillus actinomycetemcomitans and serotype distribution in human periodontal disease. Infect Immun (1983) 3.04
Periodontal infections contribute to elevated systemic C-reactive protein level. J Periodontol (2001) 2.97
Interactions between periodontal bacteria and human oral epithelial cells: Fusobacterium nucleatum adheres to and invades epithelial cells. Infect Immun (2000) 2.95
Periodontal infection and preterm birth: results of a prospective study. J Am Dent Assoc (2001) 2.94
Serum antibodies to oral Bacteroides asaccharolyticus (Bacteroides gingivalis): relationship to age and periondontal disease. Infect Immun (1981) 2.93
Specificity of salivary-bacterial interactions: II. Evidence for a lectin on Streptococcus sanguis with specificity for a NeuAc alpha 2, 3Ga1 beta 1, 3Ga1NAc sequence. Biochem Biophys Res Commun (1982) 2.81
Examination of the relation between periodontal health status and cardiovascular risk factors: serum total and high density lipoprotein cholesterol, C-reactive protein, and plasma fibrinogen. Am J Epidemiol (2000) 2.64
Inactivation of the Porphyromonas gingivalis fimA gene blocks periodontal damage in gnotobiotic rats. J Bacteriol (1994) 2.59
Treatment of periodontal disease in diabetics reduces glycated hemoglobin. J Periodontol (1997) 2.39
Black-pigmented Bacteroides spp. in the human oral cavity. Infect Immun (1981) 2.38
Inhibition of glucosyltransferase activity by antisera to known serotypes of Streptococcus mutans. Infect Immun (1973) 2.37
Molecular cloning and sequencing of the gene encoding the fimbrial subunit protein of Bacteroides gingivalis. J Bacteriol (1988) 2.25
Actinobacillus actinomycetemcomitans in human periodontal disease. Prevalence in patient groups and distribution of biotypes and serotypes within families. J Periodontol (1983) 2.23
Periodontal disease in non-insulin-dependent diabetes mellitus. J Periodontol (1991) 2.18
Assessment of risk for periodontal disease. II. Risk indicators for alveolar bone loss. J Periodontol (1995) 2.15
Role of salivary mucins in the protection of the oral cavity. J Oral Pathol (1982) 2.14
Molecular cloning, sequence, and specificity of expression of the gene encoding the low molecular weight human salivary mucin (MUC7). J Biol Chem (1993) 2.11
Heterogeneity of virulence among strains of Bacteroides gingivalis. J Periodontal Res (1989) 1.99
Interaction of a salivary mucin-secretory immunoglobulin A complex with mucosal pathogens. Infect Immun (1991) 1.93
Human immune responses to oral micro-organisms. I. Association of localized juvenile periodontitis (LJP) with serum antibody responses to Actinobacillus actinomycetemcomitans. Clin Exp Immunol (1982) 1.93
Synthetic peptides analogous to the fimbrillin sequence inhibit adherence of Porphyromonas gingivalis. Infect Immun (1992) 1.90
Severe periodontitis and risk for poor glycemic control in patients with non-insulin-dependent diabetes mellitus. J Periodontol (1996) 1.90
Host responses in periodontal diseases. J Dent Res (1984) 1.90
Purification and properties of hemagglutinin from culture supernatant of Bacteroides gingivalis. Infect Immun (1986) 1.85
Direct hemagglutination technique for differentiating Bacteroides asaccharolyticus oral strains from nonoral strains. J Clin Microbiol (1979) 1.84
A role for fimbriae in Porphyromonas gingivalis invasion of oral epithelial cells. Infect Immun (1997) 1.84
Antigenic studies of oral and nonoral black-pigmented Bacteroides strains. Infect Immun (1980) 1.84
The Coventry Award. Polymerase chain reaction detection of bacterial infection in total knee arthroplasty. Clin Orthop Relat Res (1996) 1.83
Immunization with Porphyromonas (Bacteroides) gingivalis fimbriae protects against periodontal destruction. Infect Immun (1992) 1.82
Cloning, expression, and sequencing of a cell surface antigen containing a leucine-rich repeat motif from Bacteroides forsythus ATCC 43037. Infect Immun (1998) 1.79
Secretory gamma-A antibodies induced by local immunization. Nature (1969) 1.76
Prevention of Streptococcus mutans infection of tooth surfaces by salivary antibody in Irus monkeys (Macaca fascicularis). Infect Immun (1975) 1.74
Self-reported measures for surveillance of periodontitis. J Dent Res (2013) 1.69
Porphyromonas (Bacteroides) gingivalis fimbrillin: size, amino-terminal sequence, and antigenic heterogeneity. Infect Immun (1991) 1.67
Clinical criteria for the definition of "established periodontitis". J Periodontol (1992) 1.65
Salivary histatin 5: dependence of sequence, chain length, and helical conformation for candidacidal activity. J Biol Chem (1990) 1.63
The relationship between bone mineral density and periodontitis in postmenopausal women. J Periodontol (2000) 1.63
Tissue localization of Actinobacillus actinomycetemcomitans in human periodontitis. I. Light, immunofluorescence and electron microscopic studies. J Periodontol (1987) 1.63
Characterization of tufted streptococci isolated from the "corn cob" configuration of human dental plaque. Infect Immun (1980) 1.63
Isolation and immunochemical characterization of the group-specific antigen of Streptococcus mutants 6715. Infect Immun (1975) 1.62
Characterization of salivary alpha-amylase binding to Streptococcus sanguis. Infect Immun (1989) 1.60
Defective polymorphonuclear leukocyte function in a human periodontal disease. Nature (1977) 1.59
Type 2 diabetes mellitus and periodontal disease. J Am Dent Assoc (1990) 1.59
Position statement and guidelines on unmodified electroconvulsive therapy. Indian J Psychiatry (2012) 1.58
Blastogenic response of human lymphocytes to oral bacterial antigens: comparison of individuals with periodontal disease to normal and edentulous subjects. Infect Immun (1976) 1.56
Characterization of collagenolytic activity from strains of Bacteroides gingivalis. J Periodontal Res (1988) 1.56
Salivary alpha-amylase: role in dental plaque and caries formation. Crit Rev Oral Biol Med (1993) 1.56
Purification, characterization and immunolocalization of fimbrial protein from Porphyromonas (bacteroides) gingivalis. Biochem Biophys Res Commun (1991) 1.54
Studies of leukotoxin from Actinobacillus actinomycetemcomitans using the promyelocytic HL-60 cell line. Infect Immun (1983) 1.53
Identification of Bacteroides gingivalis by fluorescent antibody staining. Ann Microbiol (Paris) (1982) 1.53
The role of osteopenia in oral bone loss and periodontal disease. J Periodontol (1996) 1.51
Differential agar medium for separating Streptococcus lactis and Streptococcus cremoris. Appl Microbiol (1969) 1.50
Actinobacillus actinomycetemcomitans in human periodontal disease. Association, serology, leukotoxicity, and treatment. J Periodontal Res (1982) 1.50
Evidence for the role of highly leukotoxic Actinobacillus actinomycetemcomitans in the pathogenesis of localized juvenile and other forms of early-onset periodontitis. J Periodontol (2000) 1.49
Osteoporosis and oral infection: independent risk factors for oral bone loss. J Dent Res (2008) 1.48
Neutrophil chemotaxis dysfunction in human periodontitis. Infect Immun (1980) 1.48
Serum neutralizing activity against Actinobacillus actinomycetemcomitans leukotoxin in juvenile periodontitis. J Clin Periodontol (1981) 1.45
Adherence of Streptococcus sanguis to salivary mucin bound to glass. J Dent Res (1982) 1.44
Structural aspects of salivary glycoproteins. J Dent Res (1987) 1.44
Effects of temperature stress on expression of fimbriae and superoxide dismutase by Porphyromonas gingivalis. Infect Immun (1994) 1.42
Biological effects of a purified lipopolysaccharide from Bacteroides gingivalis. J Periodontal Res (1983) 1.42
The effect of systemic flurbiprofen on bone supporting dental implants. J Am Dent Assoc (1995) 1.41
Modulation of bone metabolism by two chemically distinct lipopolysaccharide fractions from Bacteroides gingivalis. Infect Immun (1986) 1.40
Characterization of in vivo salivary-derived enamel pellicle. Arch Oral Biol (1989) 1.40
Observation of an antimatter hypernucleus. Science (2010) 1.38
Surface thermodynamics of normal and pathological human granulocytes. Cell Biophys (1980) 1.38
Inhibition of neutrophil chemotaxis by soluble bacterial products. J Periodontol (1982) 1.38
Periodontal disease and NIDDM in Pima Indians. Diabetes Care (1990) 1.36
Salivary receptors for recombinant fimbrillin of Porphyromonas gingivalis. Infect Immun (1994) 1.36
Longitudinal study of prognostic factors in established periodontitis patients. J Clin Periodontol (1997) 1.36
The immunoglobulins of equine colostrum and parotid fluid. J Immunol (1969) 1.36
Actinobacillus actinomycetemcomitans in the pathogenesis of human periodontal disease. Adv Dent Res (1988) 1.36